We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 22nd:
eBay Inc. (EBAY - Free Report) : This commerce platforms operator, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.1% over the last 60 days.
Merck & Co., Inc. (MRK - Free Report) :This healthcare solutions provider, which carries a Zacks Rank #2, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.
Magellan Health, Inc. : This healthcare management services provider, which carries a Zacks Rank #2, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2% over the last 60 days.
AmerisourceBergen Corporation : This pharmaceutical products distributor, which carries a Zacks Rank #2, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Top Ranked Growth Stocks to Buy for July 22nd
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 22nd:
eBay Inc. (EBAY - Free Report) : This commerce platforms operator, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.1% over the last 60 days.
eBay Inc. Price and Consensus
eBay Inc. price-consensus-chart | eBay Inc. Quote
eBay has a PEG ratio of 1.57 compared with 2.21 for the industry. The company possesses a Growth Score of B.
eBay Inc. PEG Ratio (TTM)
eBay Inc. peg-ratio-ttm | eBay Inc. Quote
Merck & Co., Inc. (MRK - Free Report) :This healthcare solutions provider, which carries a Zacks Rank #2, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.
Merck & Co., Inc. Price and Consensus
Merck & Co., Inc. price-consensus-chart | Merck & Co., Inc. Quote
Merck has a PEG ratio of 1.73, compared with 1.92 for the industry. The company possesses a Growth Score of B.
Merck & Co., Inc. PEG Ratio (TTM)
Merck & Co., Inc. peg-ratio-ttm | Merck & Co., Inc. Quote
Magellan Health, Inc. : This healthcare management services provider, which carries a Zacks Rank #2, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2% over the last 60 days.
Magellan Health, Inc. Price and Consensus
Magellan Health, Inc. price-consensus-chart | Magellan Health, Inc. Quote
Magellan Health has a PEG ratio of 0.73, compared with 1.35 for the industry. The company possesses a Growth Score of A.
Magellan Health, Inc. PEG Ratio (TTM)
Magellan Health, Inc. peg-ratio-ttm | Magellan Health, Inc. Quote
AmerisourceBergen Corporation : This pharmaceutical products distributor, which carries a Zacks Rank #2, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.
AmerisourceBergen Corporation Price and Consensus
AmerisourceBergen Corporation price-consensus-chart | AmerisourceBergen Corporation Quote
AmerisourceBergen has a PEG ratio of 1.67, compared with 1.75 for the industry. The company possesses a Growth Score of A.
AmerisourceBergen Corporation PEG Ratio (TTM)
AmerisourceBergen Corporation peg-ratio-ttm | AmerisourceBergen Corporation Quote
See the full list of top ranked stocks here.
Learn more about the Growth score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>